Company / Operating Cash Flow
ROCKET PHARMACEUTICALS, INC. Operating Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$209.7M
FY2025
5-year range
-$209.7M / -$64.7M
FY2021-FY2025
Trend
-17.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has declined for 5 consecutive years, from -$54M in FY2020 to -$210M in FY2025.
Based on SEC 10-K filings.
-$210M in FY2025.
Declined from -$121M to -$210M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ROCKET PHARMACEUTICALS, INC.'s operating cash flow has declined for 5 consecutive years.
- In FY2025, operating cash flow decreased 17.7% year-over-year.
- Peak operating cash flow was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$209.7M | -17.7% |
| FY2024 | -$178.1M | -47.0% |
| FY2023 | -$121.2M | -62.3% |
| FY2022 | -$74.6M | -15.4% |
| FY2021 | -$64.7M | -20.2% |
| FY2020 | -$53.8M | +0.0% |
| FY2019 | -$53.8M | -877.4% |
| FY2018 | -$5.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026